Many people continue to experience breathing difficulties, fatigue, or coughing months after a SARS-CoV-2 infection—a condition known as Long COVID. But what changes in the immune system lead to lasting lung impairment?
Inhalable mRNA vaccines could block infections directly at the site of entry. A newly developed nanoparticle system protects the mRNA as it passes through the airways and ensures an effective immune response in the lungs.
Influenza infections can severely compromise the lung’s immune defense, making patients more susceptible to secondary bacterial infections. DZL scientists have identified a key mechanism by which specialized immune cells in the lungs are depleted during...
Post-COVID – also known as Long COVID – affects millions of people worldwide and causes persistent symptoms, the underlying mechanisms of which are still not fully understood. An interdisciplinary research team has now identified new...
In a recent study by DZL researchers at the UGMLC site, a previously unknown mechanism regulating the immune response in the lungs was identified. The findings were published in the prestigious journal Science Immunology
Two DZL early-career researchers from the BREATH site have been selected for the National Translational Tandem Program for Gene- and Cell-Based Therapies (nTTP-GCT). Their interdisciplinary team, combining basic research and clinical expertise, aims to develop...
The COVIDOM+ study, led by Kiel University Medicine with the involvement of UKSH and CAU, has received €4.9 million in funding to research the long-term effects of COVID-19. The aim is to develop more precise...
A team of researchers at the University of Marburg has discovered a potential biomarker for predicting the course of disease in community-acquired pneumonia.
Artificial ventilation can save lives but also strain lung tissue, potentially causing further damage in patients with pre-existing lung conditions. DZL researchers have identified that even small clusters of collapsed alveoli can trigger ARDS under...
A project at the DZL site UGMLC (Giessen, Marburg, Bad Nauheim) shows that bacteria protect themselves against a reserve antibiotic by releasing more vesicles.
A highlight of the German Respiratory Society (DGP) congress for the DZL was the Lung Patient Forum on March 19, 2024: Approximately 200 individuals with lung diseases seized the opportunity to pose their questions to...
A group led by Marburg-based DZL researcher Professor Dr Bernd Schmeck has studied how the respiratory tract reacts to infection with pneumococci, the most important pathogen causing pneumonia.
